Applicant, as named in the Orange Book
Glaxosmithkline Llc
Next listed expiry: Lamictal Xr on 7 Jan 2029. 1 products with live protection, 4 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Lamictal Xr · 6 strengths lamotrigine | 7 Jan 2029 |
Recent events
- 25 Oct 2026Lamictal Odt · Generic approved 8 Jan 2026
- 25 Oct 2026Requip Xl · Generic approved 10 Nov 2025
- 25 Oct 2026Lamictal Odt · Generic approved 7 Oct 2025
- 25 Oct 2026Lamictal Odt · Generic approved 25 Feb 2026
Products without listed protection (4)
| Drug | Earliest generic entry |
|---|---|
| Lamictal · 4 strengths lamotrigine | open now |
| Lamictal Cd · 3 strengths lamotrigine | open now |
| Lamictal Odt · 4 strengths lamotrigine | open now |
| Mepron atovaquone | open now |